Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2012

Feb 16, 2012

30016_dirs_2012-02-16_f967cb57-fb72-46cd-ba60-bd6d5dc6c7f8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2012-02-14

Reporting Person: Williams Michael J PhD (Corporate Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-02-14 Common Stock M 258 Acquired 9610 Direct
2012-02-14 Common Stock M 399 Acquired 10009 Direct
2012-02-14 Common Stock M 400 Acquired 10409 Direct
2012-02-14 Common Stock M 343 Acquired 10752 Direct
2012-02-14 Common Stock M 476 Acquired 11228 Direct
2012-02-14 Common Stock F 623 $87.42 Disposed 10605 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-02-14 Non-Qualified Stock Option (right to buy) $87.42 A 11662 Acquired 2019-02-13 Common Stock (11662) Direct
2012-02-14 Incentive Stock Option (right to buy) $87.42 A 1143 Acquired 2019-02-13 Common Stock (1143) Direct
2012-02-14 Restricted Stock Unit $ A 1287 Acquired Common Stock (1287) Direct
2012-02-14 Restricted Stock Unit $ M 258 Disposed Common Stock (258) Direct
2012-02-14 Restricted Stock Unit $ M 399 Disposed Common Stock (399) Direct
2012-02-14 Restricted Stock Unit $ M 400 Disposed Common Stock (400) Direct
2012-02-14 Restricted Stock Unit $ M 343 Disposed Common Stock (343) Direct
2012-02-14 Restricted Stock Unit $ M 476 Disposed Common Stock (476) Direct

Footnotes

F1: Includes 56 shares, 75 shares and 67 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on 06/30/2011, 09/30/2011 and 12/30/2011, respectively.

F2: Grant of options to buy shares of common stock becomes exercisable as to 2,561 shares on 02/14/2013, 02/14/2014, 02/14/2015, 02/14/2016, and the remaining 1,418 shares on 02/14/2017.

F3: Grant of options to buy shares of common stock that vest on the fifth anniversary date (02/14/2017) of the grant.

F4: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2013) of the date of grant.

F5: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2012) of the date of grant.

F6: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2011) of the date of grant.

F7: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2010) of the date of grant.

F8: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2009) of the date of grant.

F9: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2008) of the date of grant.